DPPIV

DPPIV

DPPIV Overview

Molecule Name
Dipeptidyl peptidase IV
Synonyms
DPP4,ADABP,ADCP2,CD26,DPPIV,TP103
Drug Development Progress
Drugs in Clinical Trials37
Approved Drugs42
Highest Development StageApproved
Target Synonym
Dipeptidyl peptidase IV membrane form,T-cell activation antigen CD26,Adenosine deaminase complexing protein 2,Dipeptidyl peptidase IV,Dipeptidyl peptidase IV soluble form,ADCP2,Dipeptidyl peptidase 4,ADCP-2,ADABP,DPP4,Dipeptidylpeptidase IV (CD26, Adenosine Deaminase Complexing Protein 2),DPP IV,TP103,CD26,Dipeptidyl-Peptidase 4,Dipeptidylpeptidase 4,CD26 Antigen,DPPIV,Xaa-Pro-Dipeptidylaminopeptidase,Gly-Pro Naphthylamidase,Post-Proline Dipeptidyl Aminopeptidase IV
Background
Dipeptidyl peptidase-IV (DPPIV) is also known as adenosine deaminase complexing protein 2, DPPIV or CD26 is antigenic enzyme expressed on the surface of most cell types and is associated with immune regulation, signal transduction and apoptosis. It is an intrinsic membrane glycoprotein and a serine exopeptidase that cleaves X-proline dipeptides from the N-terminus of polypeptides. The substrates of DPPIV are proline (or alanine)-containing peptides and include growth factors, chemokines, neuropeptides, and vasoactive peptides. DPPIV plays a major role in glucose metabolism. It is responsible for the degradation of incretins such as GLP-1. DPPIV plays an important role in tumor biology, and is useful as a marker for various cancers, with its levels either on the cell surface or in the serum increased in some neoplasms and decreased in others. DPPIV also binds the enzyme adenosine deaminase specifically and with high affinity. The significance of this interaction has yet to be established.

DPPIV Product List

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
Dutogliptin TartrateREC-01; PHX-1149; PHX-1149TPhase 3 ClinicalPhenomix
Diabetes Mellitus, Type 2; Leukemia, Myeloid, Acute; Myocardial Infarction; Renal Insufficiency; ST Elevation Myocardial Infarction
Details
YogliptinPhase 3 ClinicalChengdu Easton Biopharmaceuticals Co Ltd, Sichuan Sunheal Pharmaceutical Co Ltd
Diabetes Mellitus, Type 2
Details
Empagliflozin/Sitagliptin HydrochlorideDW1026C1; DW-1026C1; DW1026C2; DW-1026C2Phase 3 ClinicalDaewon Pharmaceutical Co Ltd
Diabetes Mellitus, Type 2
Details
Dapagliflozin formate/LinagliptinIN-C009; AJU-A51Phase 3 ClinicalAju Pharm Co Ltd, HK inno.N Corporation
Diabetes Mellitus, Type 2
Details
DA5221-B2DA5221-B2Phase 3 ClinicalDong-A ST Co Ltd
Diabetes Mellitus, Type 2
Details
LID104LID104; LID-104Phase 3 ClinicalEms
Diabetes Mellitus, Type 2
Details
Empagliflozin/Metformin/Sitagliptin (Chong Kun Dang Pharmaceutical)CKD-379Phase 3 ClinicalChong Kun Dang Pharmaceutical Corp
Diabetes Mellitus; Diabetes Mellitus, Type 2
Details
TOTUM•63TOTUM-63Phase 3 ClinicalValbiotis
Diabetes Mellitus, Type 2
Details
TalabostatVbP; PT-100; BXCL-701Phase 2 ClinicalPoint Therapeutics
Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Small Cell; CNS Embryonal Tumor; Kidney Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Liver Neoplasms; Lung Neoplasms; Melanoma; Myelodysplastic Syndromes; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Neuroblastoma; Neuroendocrine Tumors; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Sarcoma; Skin Neoplasms; Solid tumours
Details
TQ-F3083TQ-F3083; CT-383Phase 2 ClinicalBeijing Centaurus Biopharma Co Ltd, Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd
Diabetes Mellitus; Diabetes Mellitus, Type 2
Details
BegelomabSAND-26; BT 5/9Phase 2 ClinicalAdienne
Dermatomyositis; Graft vs Host Disease
Details
SingletineDC-291407; DC-407; DC291407Phase 2 ClinicalCisen Pharmaceutical Co Ltd, Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences
Diabetes Mellitus, Type 2; Fatty Liver
Details
GCP-002EP-HMRGPhase 2 ClinicalGoryo Chemical Inc
Esophageal Neoplasms
Details
Metformin/Dapagliflozin/SitagliptinGMRx4Phase 2 ClinicalGeorge Medicines PTY Ltd, George Medicines UK Ltd
Diabetes Mellitus, Type 2
Details
Bogliptin maleateHL012MAPhase 2 ClinicalEast China University Of Science And Technology, Shandong Baiji Dichang Pharmaceutical Co Ltd, Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences
Diabetes Mellitus, Type 2
Details
CKD-393CKD-393Phase 1 ClinicalChong Kun Dang Pharmaceutical Corp
Diabetes Mellitus, Type 2
Details
Augliptin HydrochloridePhase 1 ClinicalNanjing Changao Pharmaceutical Science And Technologyco Ltd, Shanghai Sun-Sail Pharmaceutical Science & Technology Co Ltd
Diabetes Mellitus, Type 2
Details
Evogliptin TartrateLY-05007Phase 1 ClinicalDong-A Pharmaceutical Co Ltd
Diabetes Mellitus, Type 2
Details
Sitagliptin/TelmisartanHDDO-16091 + HDDO-16092; HOB-077; HDDO-1609Phase 1 ClinicalHyundai Pharmaceutical Co Ltd
Diabetes Mellitus; Hypertension
Details
TSL-0319TSL-0319Phase 1 ClinicalJiangsu Tasly Diyi Pharmaceutical Co Ltd
Diabetes Mellitus, Type 2
Details
Prusogliptin/Dapagliflozin/MetforminPhase 1 ClinicalCspc Ouyi Pharmaceutical Co Ltd
Diabetes Mellitus, Type 2
Details
Vildagliptin and Metformin Hydrochloride Extended-Release Tablets(24h)(Taizhou Overseas Pharma)Phase 1 ClinicalTaizhou Overseas Pharmaceuticals Co Ltd
Diabetes Mellitus, Type 2
Details
Vildagliptin and Metformin Hydrochloride Extended-Release Tablets(Taizhou Overseas Pharma)Phase 1 ClinicalTaizhou Overseas Pharmaceuticals Co Ltd
Diabetes Mellitus, Type 2
Details
Alogliptin and Metformin Hydrochloride Sustained-release Tablets(Taizhou Overseas Pharma)Phase 1 ClinicalTaizhou Overseas Pharmaceuticals Co Ltd
Diabetes Mellitus, Type 2
Details
CTL-02CTL-02; CTL02Phase 1 ClinicalCelltrion Inc
Details
Vildagliptin Sustained-release Tablets(Taizhou Overseas Pharma)Phase 1 ClinicalTaizhou Overseas Pharmaceuticals Co Ltd
Diabetes Mellitus, Type 2
Details
AJU-A53AJU-A53Phase 1 ClinicalAju Pharm Co Ltd
Diabetes Mellitus, Type 2
Details
CKD-393(2)CKD-393(2)Phase 1 ClinicalChong Kun Dang Pharmaceutical Corp
Diabetes Mellitus, Type 2
Details
ZHB-015ZHB-015; ZHB015; ZHB-C003Phase 1 ClinicalZonhon Biopharma Institute Inc
Solid tumours
Details
CMR-316CMR316; CMR-316Phase 1 ClinicalThe Calibr-Skaggs Institute for Innovative Medicines
Idiopathic Pulmonary Fibrosis; Pulmonary Disease, Chronic Obstructive; Respiratory Distress Syndrome, Adult
Details
Vildagliptin/Empagliflozin/Metformin HydrochloridePhase 1 ClinicalTaizhou Overseas Pharmaceuticals Co Ltd
Diabetes Mellitus; Diabetes Mellitus, Type 2
Details
CGT-2201CGT-2201Phase 1 ClinicalCgenetech(Suzhou China) Co Ltd
Diabetes Mellitus; Diabetes Mellitus, Type 2
Details
Empagliflozin/Metformin/Sitagliptin (Overseas Pharmaceuticals)Phase 1 ClinicalTaizhou Overseas Pharmaceuticals Co Ltd
Diabetes Mellitus, Type 2
Details
THDBH-100THDBH100; THDBH101Phase 1 ClinicalWuxi Apptec(Shanghai) Co Ltd
Diabetes Mellitus, Type 2
Details
WXSHC-071WXSHC-071Phase 1 ClinicalDongbao Zixing (Hangzhou) Biological Medicine Co Ltd
Diabetes Mellitus, Type 2
Details
REC-04ClinicalRecardio Inc
Cardiovascular Diseases
Details
DASH inhibitor (Bach)ClinicalBach Biosciences LLC
Neoplasms
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyFirst Brand NameFirst Approved CountryFirst IndicationFirst Approved CompanyFirst Approved DateIndicationClinical Trial
Gemigliptin L-tartrate SesquihydrateLC-150444; LC-15-0444ApprovedLg Chemical LtdGemiglo, ZemigloSouth KoreaDiabetes Mellitus, Type 2Lg Chemical Ltd2012-06-27
Diabetes Mellitus, Type 2; Fasting; Hepatic Insufficiency
Details
Gemigliptin L-tartrate Sesquihydrate/Metformin HydrochlorideApprovedLg Chemical LtdZemiMet SRSouth KoreaDiabetes Mellitus, Type 2Lg Chemical Ltd2015-01-01
Diabetes Mellitus, Type 2
Details
Teneligliptin Hydrobromide Hydrate/Metformin HydrochlorideApprovedHandok IncTenelia M SRSouth KoreaDiabetes Mellitus, Type 2Handok Inc2015-11-03
Diabetes Mellitus, Type 2
Details
EvogliptinDA-1229; RNV-1001ApprovedDong-A Pharmaceutical Co LtdSugarnon, Evodine, Suganon, SUGANONSouth KoreaDiabetes Mellitus, Type 2Dong-A Pharmaceutical Co Ltd2015-10-02
Aortic valve diseases; Diabetes Mellitus, Type 2; Liver Dysfunction; Renal Insufficiency
Details
Saxagliptin HydrateBMS-477118; BMS-477118-11; OPC-262ApprovedBristol-Myers Squibb Company安立泽, OnglyzaEUDiabetes Mellitus, Type 2Astrazeneca Ab2009-07-31
Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Hypoglycemia
Details
Teneligliptin Hydrobromide HydrateMP-513ApprovedMitsubishi Tanabe PharmaTenglyn, TeneliaJapanDiabetes Mellitus, Type 2Mitsubishi Tanabe Pharma, Daiichi Sankyo Co Ltd2012-06-29
Diabetes Mellitus, Type 2
Details
Retagliptin PhosphateSP-2086 Phosphate; SP 2086ApprovedJiangsu Hengrui Medicine Co Ltd瑞泽唐Mainland ChinaDiabetes Mellitus, Type 2Jiangsu Hengrui Medicine Co Ltd2023-06-27
Diabetes Mellitus; Diabetes Mellitus, Type 2; Renal Insufficiency
Details
Sitagliptin Phosphate Monohydrate/Ipragliflozin L-ProlineMK-0431JApprovedAstellas Pharma Inc, Merck & Co IncSujanuJapanDiabetes Mellitus, Type 2null2018-03-23
Diabetes Mellitus, Type 2
Details
PrusogliptinDBPR-108ApprovedNational Health Research Institutes, Taiwan Shenlong Co Ltd善泽平Mainland ChinaDiabetes Mellitus, Type 2Cspc Ouyi Pharmaceutical Co Ltd2025-01-08
Diabetes Mellitus, Type 2; Hepatic Insufficiency; Renal Insufficiency
Details
LinagliptinBI-1356; BI-1356-BSApprovedBoehringer Ingelheim International Gmbh欧唐宁, Ondero, Trajenta, Trayenta, Trazenta, TradjentaUnited StatesDiabetes Mellitus, Type 2Boehringer Ingelheim International Gmbh2011-05-02
Albuminuria; Coronavirus Disease 2019 (COVID-19); Coronavirus Infections; Diabetes Mellitus; Diabetes Mellitus, Type 2; Endocrine System Diseases; Glucose Metabolism Disorders; Hepatic Insufficiency; Hyperglycemia; Hypertension; Inflammation; Metabolic Diseases; Prediabetic State; Renal Insufficiency; Respiratory Tract Diseases; Schizophrenia; Ventricular Dysfunction, Left
Details
Rosuvastatin Calcium/Gemigliptin L-tartrate SesquihydrateApprovedLg Chemical LtdZemiStatinSouth KoreaDiabetes Mellitus, Type 2; DyslipidemiasLg Chemical Ltd2017-07-31
Diabetes Mellitus, Type 2; Dyslipidemias
Details
Alogliptin BenzoateSYR-322; TAK-322ApprovedTakeda Pharmaceutical Co LtdNesina, 尼欣那, VipidiaJapanDiabetes Mellitus, Type 2Takeda Pharmaceutical Co Ltd2010-04-06
Acute Coronary Syndrome; Diabetes Mellitus; Diabetes Mellitus, Type 2
Details
Empagliflozin/Linagliptin/MetforminApprovedBoehringer Ingelheim International Gmbh, Eli Lilly And CompanyTrijardy XRUnited StatesDiabetes Mellitus, Type 2Boehringer Ingelheim International Gmbh2020-01-27
Diabetes Mellitus, Type 2
Details
Sitagliptin Phosphate/Metformin HydrochlorideApprovedMerck & Co IncVelmetia, Janumet, 捷诺达United StatesDiabetes Mellitus, Type 2Merck & Co Inc2007-03-30
Diabetes Mellitus, Type 2
Details
Teneligliptin Hydrobromide Hydrate/Canagliflozin HemihydrateApprovedDaiichi Sankyo Co Ltd, Mitsubishi Tanabe Pharma CorpCanaliaJapanDiabetes Mellitus, Type 2Daiichi Sankyo Co Ltd, Mitsubishi Tanabe Pharma2017-07-03
Diabetes Mellitus, Type 2
Details
Anagliptin/Metformin HydrochlorideSK-1501ApprovedSanwa Kagaku Kenkyusho Co Ltd, SuzukenMetoanaJapanDiabetes Mellitus, Type 2Sanwa Kagaku Kenkyusho Co Ltd2018-09-21
Diabetes Mellitus, Type 2
Details
Vildagliptin/Metformin HydrochlorideLMF-237ApprovedNovartis Pharma Ag宜合瑞, Eucreas, EquMet, Zomarist, Icandra, GalvusmetEUDiabetes Mellitus, Type 2Novartis Europharm Ltd2007-11-14
Diabetes Mellitus, Type 2
Details
Sentagliptin PhosphateCGT-8012ApprovedCgenetech(Suzhou China) Co Ltd盛捷维Mainland ChinaDiabetes Mellitus, Type 2Cgenetech(Suzhou China) Co Ltd2024-12-01
Diabetes Mellitus, Type 2
Details
Alogliptin Benzoate/Metformin HydrochlorideCT-L01; CT-L-01ApprovedTakeda Pharmaceutical Co LtdVipdomet, Inisync, KazanoUnited StatesDiabetes Mellitus, Type 2Takeda Pharmaceuticals USA Inc2013-01-25
Diabetes Mellitus, Type 2
Details
Fultagliptin BenzoateFCN-005; SAL067; SAL-067Approved信立汀Mainland ChinaDiabetes Mellitus, Type 2Shenzhen Salubris Pharmaceuticals Co Ltd2024-06-28
Diabetes Mellitus, Type 2; Renal Insufficiency
Details
CofrogliptinHSK7653; HSK-7653ApprovedLiaoning Haisco Pharmaceutical Co Ltd, Sichuan Haisco Pharmaceutical Co Ltd倍长平Mainland ChinaDiabetes Mellitus, Type 2Haisco Pharmaceutical Group Co Ltd2024-06-18
Diabetes Mellitus, Type 2; Glucose Intolerance; Renal Insufficiency
Details
AnagliptinSK-0403; CWP-0403ApprovedSanwa Kagaku Kenkyusho Co LtdSuiny, BeskoaJapanDiabetes Mellitus, Type 2null2012-09-28
Diabetes Mellitus, Type 2
Details
Dapagliflozin Propanediol Monohydrate/Saxagliptin HydrochlorideApprovedAstrazeneca PlcQternEUDiabetes Mellitus, Type 2Astrazeneca Ab2016-07-15
Diabetes Mellitus, Type 2
Details
Alogliptin Benzoate/Pioglitazone HydrochlorideSYR-322-4833 BLApprovedTakeda Pharmaceutical Co LtdNesinaact, Oseni, Liovel, IncresyncJapanDiabetes Mellitus, Type 2Takeda Pharmaceutical Co Ltd2011-07-01
Diabetes Mellitus, Type 2
Details
Sitagliptin Phosphate MonohydrateONO-5435A; ONO-5435; MK-0431; MK-431; L-000224715ApprovedMerck Sharp & Dohme CorpRistaben, Xelevia, Tesavel, Glactiv, 捷诺维, Januvia, DIABIT-IS XUnited StatesDiabetes Mellitus, Type 2Merck & Co Inc2006-10-16
Atherosclerosis; Carcinoma, Hepatocellular; Cardiovascular Diseases; Coronavirus Disease 2019 (COVID-19); Cystic Fibrosis; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Gastroparesis; Glucose Intolerance; Graft vs Host Disease; Heart Failure; Hepatic Insufficiency; Hepatitis C; HIV Infections; Hyperlipidemias; Inflammation; Insulin Resistance; Kidney Failure, Chronic; Leukemia, Myelogenous, Chronic; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Metabolic Dysfunction-Associated Steatotic Liver Disease; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prediabetic State; Psoriasis; Renal Insufficiency; Renal Insufficiency, Chronic
Details
Trelagliptin SuccinateTAK-472; SYR-472; SYR-111472; SYR-111472 succinateApprovedTakeda Pharmaceutical Co LtdZafatekJapanDiabetes Mellitus, Type 2Takeda Pharmaceutical Co Ltd2015-03-26
Diabetes Mellitus; Diabetes Mellitus, Type 2
Details
Evogliptin Tartrate/Metformin HydrochlorideDA-1229_01ApprovedDong-A Pharmaceutical Co LtdSugamet XRSouth KoreaDiabetes Mellitus, Type 2Dong-A Pharmaceutical Co Ltd2015-12-01
Diabetes Mellitus, Type 2
Details
Sitagliptin/ErtugliflozinApprovedPfizer IncSteglujanUnited StatesDiabetes Mellitus, Type 2Merck & Co Inc2017-12-19
Diabetes Mellitus, Type 2
Details
Retagliptin Phosphate/Metformin HydrochlorideHRX-0701; HRX0701ApprovedJiangsu Hengrui Medicine Co Ltd瑞霖唐Mainland ChinaDiabetes Mellitus, Type 2Shandong Shengdi Pharmaceutical Co Ltd2025-05-20
Diabetes Mellitus, Type 2
Details
Sitagliptin/Metformin Hydrochloride (Zydus Lifesciences)ApprovedZydus Lifesciences LtdZituvimet, ZITUVIMETUnited StatesDiabetes Mellitus, Type 2Zydus Lifesciences Ltd2023-11-03
Diabetes Mellitus, Type 2
Details
OmarigliptinMK-3102ApprovedMerck & Co IncMarizevJapanDiabetes Mellitus, Type 2Merck Sharp & Dohme Corp2015-09-28
Diabetes Mellitus; Diabetes Mellitus, Type 2; Renal Insufficiency, Chronic
Details
Henagliflozin/metformin/retagliptin (Shandong Shengdi)HR20031; HR-20031ApprovedShandong Shengdi Pharmaceutical Co Ltd瑞乐唐Mainland ChinaDiabetes Mellitus; Diabetes Mellitus, Type 2Shandong Shengdi Pharmaceutical Co Ltd2025-10-21
Diabetes Mellitus; Diabetes Mellitus, Type 2
Details
Teneligliptin/PioglitazoneApprovedGlenmark Pharmaceuticals LtdZita Plus PioIndiaDiabetes Mellitus, Type 2Glenmark Pharmaceuticals Ltd2022-04-25
Diabetes Mellitus, Type 2
Details
Dapagliflozin Propanediol Hydrate/Sitagliptin Phosphate HydrateSID-1903; DW-6012ApprovedDong Wha Pharm Co LtdSidapviaSouth KoreaDiabetes Mellitus, Type 2Dong Wha Pharm Co Ltd2023-06-30
Diabetes Mellitus, Type 2; Myocardial Infarction; ST Elevation Myocardial Infarction
Details
Metformin Hydrochloride/Sitagliptin HydrochlorideApprovedSandoz BvEUSandoz Bv2019-12-10
Details
Sitagliptin TartrateApprovedHeumann Pharma GmbH & Co Generica KGSitagliptin Heumann 25 mg FilmtablettenEUHeumann Pharma GmbH & Co Generica KG2020-12-14
Diabetes Mellitus, Type 1; Diabetic Nephropathies; Metabolic Dysfunction-Associated Steatotic Liver Disease; Parkinson Disease
Details
Sitagliptin HydrochlorideApprovedLaboratorios Alter SaSpainDiabetes Mellitus, Type 2Laboratorios Alter Sa2019-03-06
Diabetes Mellitus, Type 2; Polycystic Ovary Syndrome
Details
Gemigliptin/DapagliflozinApprovedLg Chemical LtdZemidapaSouth KoreaDiabetes Mellitus, Type 2Lg Chemical Ltd2022-06-21
Diabetes Mellitus, Type 2
Details
Linagliptin/Metformin HydrochlorideGC2129A; GC-2129-A; DW6013ApprovedBoehringer Ingelheim International GmbhJentadueto Xr, Trajenta Duo, Jentadueto, 欧双宁United StatesDiabetes Mellitus, Type 2Boehringer Ingelheim International Gmbh2012-01-30
Diabetes Mellitus, Type 2
Details
Linagliptin/EmpagliflozinBI 1356/BI 10773; BI 10773/linagliptin; BI 1356/empagliflozin; Empagliflozin/BI 1356; Linagliptin/BI 10773; BI 10773/BI 1356ApprovedC.H. Boehringer Sohn Ag & Co. KgTradiance, Glyxambi, EsgliteoUnited StatesDiabetes Mellitus, Type 2Boehringer Ingelheim International Gmbh2015-01-30
Cardiovascular Diseases; Diabetes Mellitus, Type 2
Details
VildagliptinLAF-237; DSP-7238; LAF-237A; NVP-LAF-237ApprovedNovartis Pharma Ag佳维乐, Equa, Jalra, Galvus, Gliptus, XiliarxEUDiabetes Mellitus, Type 2Novartis Europharm Ltd2007-09-25
Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes, Gestational; Dyslipidemias; Insulin Resistance; Prediabetic State; Renal Insufficiency; Schizophrenia
Details
Saxagliptin Hydrochloride/Metformin HydrochlorideApprovedAstrazeneca Plc安立格, Kombiglyze Xr, KomboglyzeEUDiabetes Mellitus, Type 2Astrazeneca Ab2010-11-05
Diabetes Mellitus, Type 2
Details